{"title": "Wuhan and Hubei COVID-19 mortality analysis reveals the critical role of timely supply of medical resources", "doi": "10.1101/2020.03.13.20035410", "citation_id": "2020.03.13.20035410v1", "date": "2020-03-17", "laguage": "en", "journal_title": "medRxiv", "first_page": "2020.03.13.20035410", "abstract": "<p>We report that COVID-19 mortality and recovery rates in Hubei Province, China exponentially decays (R<sup>2</sup>&gt;0.93) and grows (R<sup>2</sup>&gt;0.95), respectively. A great number of newly supplied medical resources (health workers and beds) enabled overwhelming patients to be treated effectively. This may help other countries to deal with the coming COVID-19 outbreaks.</p>", "twitter_description": "We report that COVID-19 mortality and recovery rates in Hubei Province, China exponentially decays (R2>0.93) and grows (R2>0.95), respectively. A great number of newly supplied medical resources (health workers and beds) enabled overwhelming patients to be treated effectively. This may help other countries to deal with the coming COVID-19 outbreaks.\n\n### Competing Interest Statement\n\nThe authors have declared no competing interest.\n\n### Funding Statement\n\nThis work is support by the National Natural Science Foundation of China (No. 31972918 and 31770830 to XF).\n\n### Author Declarations\n\nAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.\n\nYes\n\nAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.\n\nYes\n\nI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).\n\nYes\n\nI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.\n\nYes\n\nAll the data are included in the manuscript", "full_text_html_url": "https://www.medrxiv.org/content/10.1101/2020.03.13.20035410v1.full", "public_url": "https://www.medrxiv.org/content/10.1101/2020.03.13.20035410v1", "abstract_html_url": "https://www.medrxiv.org/content/10.1101/2020.03.13.20035410v1.abstract", "pdf_url": "https://www.medrxiv.org/content/medrxiv/early/2020/03/17/2020.03.13.20035410.full.pdf", "rights": "\u00a9 2020, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at http://creativecommons.org/licenses/by-nc-nd/4.0/", "publisher": "Cold Spring Harbor Laboratory Press", "pisa": "medrxiv;2020.03.13.20035410v1", "access_rights": "restricted", "authors": ["Zuqin Zhang", "Wei Yao", "Yan Wang", "Cheng Long", "XINMIAO FU"]}